118 related articles for article (PubMed ID: 17458842)
1. Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors.
Mai A; Valente S; Cheng D; Perrone A; Ragno R; Simeoni S; Sbardella G; Brosch G; Nebbioso A; Conte M; Altucci L; Bedford MT
ChemMedChem; 2007 Jul; 2(7):987-91. PubMed ID: 17458842
[No Abstract] [Full Text] [Related]
2. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
[TBL] [Abstract][Full Text] [Related]
3. Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9.
Mori S; Iwase K; Iwanami N; Tanaka Y; Kagechika H; Hirano T
Bioorg Med Chem; 2010 Dec; 18(23):8158-66. PubMed ID: 21036620
[TBL] [Abstract][Full Text] [Related]
4. Cancer treatment of the future: inhibitors of histone methyltransferases.
Spannhoff A; Sippl W; Jung M
Int J Biochem Cell Biol; 2009 Jan; 41(1):4-11. PubMed ID: 18773966
[TBL] [Abstract][Full Text] [Related]
5. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3.
Kunizaki M; Hamamoto R; Silva FP; Yamaguchi K; Nagayasu T; Shibuya M; Nakamura Y; Furukawa Y
Cancer Res; 2007 Nov; 67(22):10759-65. PubMed ID: 18006819
[TBL] [Abstract][Full Text] [Related]
6. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
7. Epidithiodiketopiperazine as a pharmacophore for protein lysine methyltransferase G9a inhibitors: reducing cytotoxicity by structural simplification.
Fujishiro S; Dodo K; Iwasa E; Teng Y; Sohtome Y; Hamashima Y; Ito A; Yoshida M; Sodeoka M
Bioorg Med Chem Lett; 2013 Feb; 23(3):733-6. PubMed ID: 23266120
[TBL] [Abstract][Full Text] [Related]
8. Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly.
Sampath SC; Marazzi I; Yap KL; Sampath SC; Krutchinsky AN; Mecklenbräuker I; Viale A; Rudensky E; Zhou MM; Chait BT; Tarakhovsky A
Mol Cell; 2007 Aug; 27(4):596-608. PubMed ID: 17707231
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of peptide-MCA substrates for a novel assay of histone methyltransferases and their inhibitors.
Chi H; Takemoto Y; Nsiama TK; Kato T; Nishino N; Ito A; Yoshida M
Bioorg Med Chem; 2014 Feb; 22(4):1268-75. PubMed ID: 24486204
[TBL] [Abstract][Full Text] [Related]
10. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
11. Amide-derived lysine analogues as substrates and inhibitors of histone lysine methyltransferases and acetyltransferases.
Hintzen JCJ; Merx J; Maas MN; Langens SGHA; White PB; Boltje TJ; Mecinović J
Org Biomol Chem; 2021 Dec; 20(1):173-181. PubMed ID: 34877957
[TBL] [Abstract][Full Text] [Related]
12. Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells.
Valente S; Lepore I; Dell'Aversana C; Tardugno M; Castellano S; Sbardella G; Tomassi S; Di Maro S; Novellino E; Di Santo R; Costi R; Altucci L; Mai A
Biochimie; 2012 Nov; 94(11):2308-13. PubMed ID: 22709867
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming the histone code.
Shaaban SA; Bedford MT
Chem Biol; 2007 Mar; 14(3):242-4. PubMed ID: 17379139
[No Abstract] [Full Text] [Related]
14. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9.
Greiner D; Bonaldi T; Eskeland R; Roemer E; Imhof A
Nat Chem Biol; 2005 Aug; 1(3):143-5. PubMed ID: 16408017
[TBL] [Abstract][Full Text] [Related]
15. Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment.
Zagni C; Chiacchio U; Rescifina A
Curr Med Chem; 2013; 20(2):167-85. PubMed ID: 23210854
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of (+)-chaetocin and its analogues: their histone methyltransferase G9a inhibitory activity.
Iwasa E; Hamashima Y; Fujishiro S; Higuchi E; Ito A; Yoshida M; Sodeoka M
J Am Chem Soc; 2010 Mar; 132(12):4078-9. PubMed ID: 20210309
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
[TBL] [Abstract][Full Text] [Related]
18. Regulation and function of H3K9 methylation.
Shinkai Y
Subcell Biochem; 2007; 41():337-50. PubMed ID: 17484135
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
[TBL] [Abstract][Full Text] [Related]
20. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
